Beclophar 400 µg inhal. pwdr. (hard caps.) Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

beclophar 400 µg inhal. pwdr. (hard caps.)

sandoz sa-nv - beclometasone dipropionate 400 µg - eq. beclometasone 314 µg - inhalation powder, hard capsule - 400 µg - beclometasone dipropionate 400 µg - beclometasone

HIGHLIGHTS OF PRESCRIBING INFORMATION United States - English - NLM (National Library of Medicine)

highlights of prescribing information

teva respiratory, llc - beclomethasone dipropionate (unii: 5b307s63b2) (beclomethasone - unii:kgz1slc28z) - qnasl® nasal aerosol is indicated for the treatment of the nasal symptoms associated with seasonal and perennial allergic rhinitis in patients 4 years of age and older. qnasl nasal aerosol is contraindicated in patients with a history of hypersensitivity to beclomethasone dipropionate and/or any other qnasl nasal aerosol ingredients [see warnings and precautions (5.3)] . teratogenic effects : pregnancy category c there are no adequate and well-controlled clinical trials in pregnant women treated with qnasl nasal aerosol. beclomethasone dipropionate was teratogenic and embryocidal in the mouse and rabbit although these effects were not observed in rats. qnasl nasal aerosol should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. experience with oral corticosteroids since their introduction in pharmacologic, as opposed to physiologic, doses suggests that rodents are more prone to teratogenic effects from corticosteroids than humans. beclomethasone dipropionate ad

TRIMBOW Israel - English - Ministry of Health

trimbow

kamada ltd, israel - beclometasone dipropionate; formoterol fumarate dihydrate; glycopyrronium as bromide - pressurised solution - glycopyrronium as bromide 9 mcg/delivered dose; formoterol fumarate dihydrate 5.2 mcg/delivered dose; beclometasone dipropionate 87.4 mcg/delivered dose - formoterol, glycopyrronium bromide and beclometasone - copd maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist. asthma maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.…

Beclomet-NS Nasal Spray Bangladesh - English - DGDA (Directorate General of Drug Administration)

beclomet-ns nasal spray

the acme laboratories ltd. - beclomethasone dipropionate - nasal spray - 1 mcg/spray